MedTrace Logo

Efficacy of Intracavernous Platelet-rich Plasma Injection in the Treatment of Erectile Dysfunction

NCT06942988 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2025-04-24

No results posted yet for this study

Summary

Investigation of the efficacy of autologous platelet-rich plasma administration on the potency of patients with vasculogenic and/or neurogenic erectile dysfunction

Conditions

Interventions

BIOLOGICAL

intracavernous platelet rich plasma therapy

intracavernous platelet-rich plasma therapy for erectile dysfunction

Sponsors & Collaborators

  • t-biyoteknoloji labaratuvar estetik medikal kozmetik san. ve tic. ltd. şti.

    collaborator UNKNOWN

  • Bakirkoy Dr. Sadi Konuk Research and Training Hospital

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-29
Primary Completion
2025-07-29
Completion
2025-07-29

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06942988 on ClinicalTrials.gov